CN Patent

CN114269738B — 一种mor受体激动剂化合物、制备方法及其用途

Assigned to Chengdu Easton Biopharmaceuticals Co Ltd · Expires 2023-09-29 · 3y expired

What this patent protects

本发明涉及药物化学领域，具体涉及一类6‑氧杂螺[4.5]癸烷类衍生物作为MOR受体激动剂的用途，用于治疗如疼痛和疼痛相关的紊乱。

USPTO Abstract

本发明涉及药物化学领域，具体涉及一类6‑氧杂螺[4.5]癸烷类衍生物作为MOR受体激动剂的用途，用于治疗如疼痛和疼痛相关的紊乱。

Drugs covered by this patent

Patent Metadata

Patent number
CN114269738B
Jurisdiction
CN
Classification
—
Expires
2023-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Easton Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.